ARTIVION, INC. (AORT) Current Ratio
- Current ratio · latest quarter: Value 3.47×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.47× | Current assets / current liabilities. $371.38M ÷ $106.93M ≈ 3.47× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 371.38M USD | Assets, Current |
| Current obligations | 106.93M USD | Liabilities, Current |
| Cash and equivalents | 77.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 97.93M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 103.36M USD | Inventory, Net |
| Payables | 20.87M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $371.38M | $106.93M | $77.32M | (m) | $97.93M | $103.36M | $20.87M | $0.00 | 3.47× |
| 2026-03-31 | $357.52M | $92.70M | $55.76M | (m) | $91.87M | $98.00M | $18.34M | $0.00 | 3.86× |
| 2025-12-31 | $358.08M | $101.56M | $64.91M | (m) | $89.76M | $92.43M | $16.04M | $0.00 | 3.53× |
| 2025-09-30 | $337.50M | $85.84M | $73.43M | (m) | $88.11M | $90.55M | $16.50M | $0.00 | 3.93× |
| 2025-06-30 | $318.82M | $66.67M | $53.48M | (m) | $91.44M | $86.72M | $19.43M | $73.00K | 4.78× |
| 2025-03-31 | $287.30M | $51.94M | $37.69M | (m) | $87.80M | $81.93M | $11.70M | $135.00K | 5.53× |
| 2024-12-31 | $290.08M | $66.82M | $53.46M | (m) | $79.46M | $79.77M | $17.97M | $195.00K | 4.34× |
| 2024-09-30 | $287.96M | $152.84M | $56.17M | (m) | $75.69M | $84.12M | $11.15M | $99.70M | 1.88× |
| 2024-06-30 | $284.96M | $50.58M | $55.02M | (m) | $73.89M | $80.80M | $11.73M | $268.00K | 5.63× |
| 2024-03-31 | $276.79M | $45.83M | $51.12M | (m) | $74.30M | $81.72M | $10.38M | $270.00K | 6.04× |
| 2023-12-31 | $280.67M | $57.86M | $58.94M | (m) | $71.80M | $81.98M | $13.32M | $1.45M | 4.85× |
| 2023-09-30 | $267.11M | $54.96M | $53.48M | (m) | $64.28M | $78.79M | $10.82M | $1.55M | 4.86× |
| 2023-06-30 | $263.90M | $56.23M | $48.77M | (m) | $64.81M | $78.46M | $10.46M | $1.56M | 4.69× |
| 2023-03-31 | $240.68M | $43.96M | $30.77M | (m) | $62.76M | $76.27M | $9.47M | $1.62M | 5.47× |
| 2022-12-31 | $247.33M | $49.67M | $39.35M | (m) | $61.82M | $74.48M | $12.00M | $1.61M | 4.98× |
| 2022-09-30 | $237.99M | $45.99M | $37.57M | (m) | $57.16M | $73.04M | $10.72M | $1.56M | 5.17× |
| 2022-06-30 | $240.43M | $41.65M | $40.38M | (m) | $57.56M | $74.32M | $10.54M | $1.59M | 5.77× |
| 2022-03-31 | $244.53M | $42.84M | $51.41M | (m) | $55.00M | $76.21M | $9.23M | $1.62M | 5.71× |
| 2021-12-31 | $247.70M | $44.95M | $55.01M | (m) | $53.02M | $76.97M | $10.39M | $1.63M | 5.51× |
| 2021-09-30 | $257.34M | $61.13M | $64.59M | (m) | $49.68M | $78.32M | $9.53M | $1.64M | 4.21× |
| 2021-06-30 | $238.05M | $58.94M | $50.47M | (m) | $49.67M | $76.36M | $10.77M | $1.65M | 4.04× |
| 2021-03-31 | $235.68M | $58.02M | $56.55M | (m) | $48.32M | $73.38M | $8.95M | $1.17M | 4.06× |
| 2020-12-31 | $234.59M | $60.47M | $61.41M | (m) | $45.96M | $73.04M | $9.62M | $1.20M | 3.88× |
| 2020-09-30 | $233.70M | $53.67M | $64.12M | (m) | $46.91M | $69.40M | $10.40M | $1.17M | 4.35× |
| 2020-06-30 | $287.12M | $48.93M | $125.63M | (m) | $45.22M | $62.71M | $10.08M | $1.14M | 5.87× |
| 2020-03-31 | $214.08M | $43.69M | $63.38M | (m) | $48.72M | $54.30M | $10.45M | $1.16M | 4.90× |
| 2019-12-31 | $187.39M | $45.20M | $33.77M | (m) | $52.94M | $53.07M | $9.80M | $1.16M | 4.15× |
| 2019-09-30 | $181.35M | $42.19M | $36.69M | (m) | $50.55M | $48.40M | $7.46M | $1.14M | 4.30× |
| 2019-06-30 | $188.56M | $37.47M | $39.75M | (m) | $54.77M | $45.42M | $6.94M | $1.16M | 5.03× |
| 2019-03-31 | $178.65M | $36.42M | $40.34M | (m) | (m) | $44.12M | $5.42M | $1.15M | 4.90× |
| 2018-12-31 | $179.17M | $34.52M | $41.49M | (m) | $47.11M | $45.48M | $7.55M | $1.16M | 5.19× |
| 2018-09-30 | $173.95M | $30.75M | $34.56M | (m) | (m) | $46.15M | $5.94M | $1.27M | 5.66× |
| 2018-06-30 | $169.70M | $34.12M | $24.96M | (m) | (m) | $45.79M | $9.26M | $1.27M | 4.97× |
| 2018-03-31 | $166.81M | $32.89M | $26.58M | (m) | (m) | $44.59M | $7.57M | $1.29M | 5.07× |
| 2017-12-31 | $179.28M | $42.94M | $39.98M | (m) | $47.52M | $46.68M | $9.77M | $718.00K | 4.18× |
| 2017-09-30 | $155.59M | $26.11M | $54.24M | (m) | (m) | $27.76M | $5.07M | $3.23M | 5.96× |
| 2017-06-30 | $152.21M | $25.77M | $52.51M | (m) | (m) | $26.54M | $6.57M | $3.23M | 5.91× |
| 2017-03-31 | $149.19M | $28.15M | $58.88M | (m) | (m) | $25.80M | $7.29M | $4.79M | 5.30× |
| 2016-12-31 | $147.23M | $30.10M | $56.64M | (m) | $27.77M | $26.29M | $5.74M | $4.56M | 4.89× |
| 2016-09-30 | $142.09M | $24.76M | $54.13M | (m) | (m) | $25.53M | $5.69M | $1.80M | 5.74× |
| 2016-06-30 | $135.78M | $24.74M | $46.94M | (m) | (m) | $25.39M | $5.20M | $1.80M | 5.49× |
| 2016-03-31 | $129.24M | $24.84M | $44.83M | (m) | (m) | $25.29M | $5.55M | $1.33M | 5.20× |
| 2015-12-31 | $109.66M | $19.61M | $37.59M | (m) | $23.42M | $14.64M | $4.59M | (m) | 5.59× |
| 2015-09-30 | $112.83M | $22.23M | $38.50M | (m) | (m) | $14.43M | $4.64M | (m) | 5.08× |
| 2015-06-30 | $108.63M | $19.19M | $35.08M | (m) | (m) | $13.51M | $4.10M | (m) | 5.66× |
| 2015-03-31 | $103.35M | $17.20M | $32.41M | (m) | (m) | $13.51M | $3.97M | (m) | 6.01× |
| 2014-12-31 | $106.03M | $20.63M | $33.38M | (m) | $21.06M | $12.74M | $4.50M | (m) | 5.14× |
| 2014-09-30 | $102.63M | $20.00M | $29.82M | (m) | (m) | $13.16M | $5.39M | (m) | 5.13× |
| 2014-06-30 | $105.78M | $19.13M | $30.87M | (m) | (m) | $12.09M | $4.88M | (m) | 5.53× |
| 2014-03-31 | $105.85M | $18.36M | $32.76M | (m) | (m) | $11.49M | $5.00M | (m) | 5.76× |
| 2013-12-31 | $106.33M | $20.72M | $37.64M | (m) | $17.84M | $9.77M | $4.14M | (m) | 5.13× |
| 2013-09-30 | $84.89M | $20.23M | $17.68M | (m) | (m) | $10.21M | $4.94M | (m) | 4.20× |
| 2013-06-30 | $77.95M | $18.82M | $11.73M | (m) | (m) | $10.84M | $3.73M | (m) | 4.14× |
| 2013-03-31 | $73.75M | $16.58M | $8.63M | (m) | $19.88M | $10.21M | $2.86M | (m) | 4.45× |
| 2012-12-31 | $77.50M | $21.43M | $13.01M | (m) | $15.94M | $10.56M | $3.16M | (m) | 3.62× |
| 2012-09-30 | $72.23M | $19.86M | $7.79M | (m) | $17.32M | $10.25M | $3.66M | (m) | 3.64× |
| 2012-06-30 | $75.20M | $24.83M | $4.00M | (m) | $17.41M | $9.67M | $8.15M | (m) | 3.03× |
| 2012-03-31 | $84.53M | $20.80M | $21.15M | (m) | (m) | $7.93M | $4.27M | (m) | 4.06× |
| 2011-12-31 | $83.87M | $21.46M | $21.70M | (m) | $15.77M | $7.32M | $4.37M | (m) | 3.91× |
| 2011-09-30 | $88.85M | $22.28M | $21.05M | (m) | (m) | $7.00M | $5.02M | (m) | 3.99× |
| 2011-06-30 | $87.58M | $19.86M | $19.80M | (m) | (m) | $6.22M | $4.12M | (m) | 4.41× |
| 2010-12-31 | $101.49M | $19.33M | $35.50M | (m) | $13.72M | $6.43M | $4.24M | (m) | 5.25× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |